HARTFORD — The Hartford HealthCare Cancer Institute (HHCCI) will be formally certified on September 16 as a charter member of the Memorial Sloan Kettering (MSK) Cancer Alliance, an initiative to improve quality of care and outcomes for cancer patients in community health-care settings. The Cancer Institute comprises five cancer centers — one at each of Hartford HealthCare’s acute-care hospitals statewide.


The certification of the Hartford HealthCare Cancer Institute as a member of the MSK Cancer Alliance comes after one year of intensive review and assessment of all the cancer programs and services within the Institute. The five cancer centers included are at the William W. Backus Hospital in Norwich, Hartford Hospital, MidState Medical Center in Meriden, the Hospital of Central Connecticut in New Britain and Windham Hospital.


The Cancer Institute’s membership in the MSK Cancer Alliance will bring numerous benefits to patients, both in the short- and long-term, including:

• Enhanced treatments and clinical care, including standards that align with MSK for surgical procedures, chemotherapy and radiation therapy

• Access to cutting edge research, including MSK’s clinical trials and protocols and breakthroughs in promising new fields such as molecular oncology

• Collaboration with some of the most pre-eminent cancer specialists in the world, working together to develop the best care plans for each patient.